Methylphenidate, fluoxetin, risperidone ( DrugBank: Methylphenidate, Fluoxetin, Risperidone )

---

2 diseases

告示番号	疾患名（ページ内リンク）	臨床試験数
179	ウィリアムズ症候群	1
206	脆弱Ｘ症候群	1

179. ウィリアムズ症候群

---

臨床試験数 : 5 /  薬物数 : 14 - (DrugBank : 8) / 標的遺伝子数 : 9 - 標的パスウェイ数 : 33

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT00768820 (ClinicalTrials.gov)	May 2001	7/10/2008	The Psychiatric and Cognitive Phenotypes in Velocardiofacial Syndrome	The Psychiatric and Cognitive Phenotypes in Velocardiofacial Syndrome (VCFS), Williams Syndrome (WS)and Fragile X Syndrome Characterization, Treatment and Examining the Connection to Developmental and Molecular Factors	Velocardiofacial Syndrome;Williams Syndrome;Fragile X Syndrome	Drug: methylphenidate, fluoxetin, risperidone	The Chaim Sheba Medical Center	NULL	Recruiting	N/A	N/A	All	400	Phase 4	Israel

206. 脆弱Ｘ症候群

---

臨床試験数 : 104 /  薬物数 : 87 - (DrugBank : 32) / 標的遺伝子数 : 54 - 標的パスウェイ数 : 79

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT00768820 (ClinicalTrials.gov)	May 2001	7/10/2008	The Psychiatric and Cognitive Phenotypes in Velocardiofacial Syndrome	The Psychiatric and Cognitive Phenotypes in Velocardiofacial Syndrome (VCFS), Williams Syndrome (WS)and Fragile X Syndrome Characterization, Treatment and Examining the Connection to Developmental and Molecular Factors	Velocardiofacial Syndrome;Williams Syndrome;Fragile X Syndrome	Drug: methylphenidate, fluoxetin, risperidone	The Chaim Sheba Medical Center	NULL	Recruiting	N/A	N/A	All	400	Phase 4	Israel